The M 3 -muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner
Degeneration of the cholinergic system is considered to be the underlying pathology that results in the cognitive deficit in Alzheimer's disease. This pathology is thought to be linked to a loss of signaling through the cholinergic M 1 -muscarinic receptor subtype. However, recent studies have cast doubt on whether this is the primary receptor mediating cholinergic-hippocampal learning and memory. The current study offers an alternative mechanism involving the M 3 -muscarinic receptor that is expressed in numerous brain regions including the hippocampus. We demonstrate here that M 3 -muscarinic receptor knockout mice show a deficit in fear conditioning learning and memory. The mechanism used by the M 3 -muscarinic receptor in this process involves receptor phosphorylation because a knockin mouse strain expressing a phosphorylation-deficient receptor mutant also shows a deficit in fear conditioning. Consistent with a role for receptor phosphorylation, we demonstrate that the M 3 -muscarinic receptor is phosphorylated in the hippocampus following agonist treatment and following fear conditioning training. Importantly, the phosphorylation-deficient M 3 -muscarinic receptor was coupled normally to G q/11 -signaling but was uncoupled from phosphorylation-dependent processes such as receptor internalization and arrestin recruitment. It can, therefore, be concluded that M 3 -muscarinic receptor–dependent learning and memory depends, at least in part, on receptor phosphorylation/arrestin signaling. This study opens the potential for biased M 3 -muscarinic receptor ligands that direct phosphorylation/arrestin-dependent (non-G protein) signaling as being beneficial in cognitive disorders.
Top-30
Journals
|
1
2
3
4
5
6
7
|
|
|
Handbook of Experimental Pharmacology
7 publications, 5.34%
|
|
|
Behavioural Brain Research
4 publications, 3.05%
|
|
|
Nature Reviews Drug Discovery
3 publications, 2.29%
|
|
|
Neuropharmacology
3 publications, 2.29%
|
|
|
Journal of Biological Chemistry
3 publications, 2.29%
|
|
|
European Journal of Pharmacology
3 publications, 2.29%
|
|
|
Neuromethods
3 publications, 2.29%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
3 publications, 2.29%
|
|
|
Molecular Pharmacology
2 publications, 1.53%
|
|
|
Brain Sciences
2 publications, 1.53%
|
|
|
Frontiers in Aging Neuroscience
2 publications, 1.53%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.53%
|
|
|
Nature Communications
2 publications, 1.53%
|
|
|
Psychopharmacology
2 publications, 1.53%
|
|
|
Neuropsychopharmacology
2 publications, 1.53%
|
|
|
Brain Research Bulletin
2 publications, 1.53%
|
|
|
Cellular Signalling
2 publications, 1.53%
|
|
|
British Journal of Pharmacology
2 publications, 1.53%
|
|
|
Journal of Pharmacological Sciences
2 publications, 1.53%
|
|
|
Learning and Memory
2 publications, 1.53%
|
|
|
Frontiers in Neuroscience
1 publication, 0.76%
|
|
|
American Journal of Psychiatry
1 publication, 0.76%
|
|
|
Pharmacological Reviews
1 publication, 0.76%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
1 publication, 0.76%
|
|
|
American Journal of Respiratory Cell and Molecular Biology
1 publication, 0.76%
|
|
|
Neurodegenerative disease management
1 publication, 0.76%
|
|
|
Restorative Neurology and Neuroscience
1 publication, 0.76%
|
|
|
Neuronal Signaling
1 publication, 0.76%
|
|
|
Biochemical Journal
1 publication, 0.76%
|
|
|
1
2
3
4
5
6
7
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
39 publications, 29.77%
|
|
|
Springer Nature
32 publications, 24.43%
|
|
|
Wiley
7 publications, 5.34%
|
|
|
Frontiers Media S.A.
6 publications, 4.58%
|
|
|
MDPI
6 publications, 4.58%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
4 publications, 3.05%
|
|
|
Taylor & Francis
4 publications, 3.05%
|
|
|
SAGE
3 publications, 2.29%
|
|
|
American Society for Biochemistry and Molecular Biology
3 publications, 2.29%
|
|
|
American Chemical Society (ACS)
3 publications, 2.29%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 2.29%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 2.29%
|
|
|
Portland Press
2 publications, 1.53%
|
|
|
American Psychiatric Association Publishing
1 publication, 0.76%
|
|
|
American Thoracic Society
1 publication, 0.76%
|
|
|
IOS Press
1 publication, 0.76%
|
|
|
Spandidos Publications
1 publication, 0.76%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.76%
|
|
|
Baishideng Publishing Group
1 publication, 0.76%
|
|
|
China Science Publishing & Media
1 publication, 0.76%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.76%
|
|
|
King Saud University
1 publication, 0.76%
|
|
|
Pleiades Publishing
1 publication, 0.76%
|
|
|
Asian Pacific Journal of Tropical Medicine Press
1 publication, 0.76%
|
|
|
Oxford University Press
1 publication, 0.76%
|
|
|
Cambridge University Press
1 publication, 0.76%
|
|
|
Annual Reviews
1 publication, 0.76%
|
|
|
Society for Neuroscience
1 publication, 0.76%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.